Erratum: Treatment of aspirin exacerbated respiratory disease with a low salicylate diet: a pilot crossover study (Otolaryngol Head Neck Surg (2015) 152 (42-47) DOI: 10.1177/0194599814555836));Treatment of aspirin exacerbated respiratory disease with a low salicylate diet: A pilot crossover study

Otolaryngology - Head and Neck Surgery (United States)

Volumn 152, Issue 1, 2015, Pages 42-47

  Sommer, Doron D ^a   Hoffbauer, Stephanie ^a   Au, Michael ^b   Sowerby, Leigh J ^c   Gupta, Michael K ^a   Nayan, Smriti ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

aspirin exacerbated respiratory disease; asthma; low salicylate diet; nasal polyps; salicylates; sinusitis

Indexed keywords

ACETYLSALICYLIC ACID; BUDESONIDE; CICLESONIDE; FLUTICASONE; SALBUTAMOL; SALICYLIC ACID DERIVATIVE;

ADULT; AGED; ARTICLE; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET THERAPY; DRUG HYPERSENSITIVITY; DRUG SENSITIVITY; ENDOSCOPY; FEMALE; HUMAN; MALE; NOSE POLYP; PILOT STUDY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SINGLE BLIND PROCEDURE; CHEMICALLY INDUCED; COMPLICATION; DESENSITIZATION; MIDDLE AGED; PROSPECTIVE STUDY; RESPIRATORY TRACT DISEASE; RHINITIS; SINUSITIS;

ADULT; AGED; ASPIRIN; ASTHMA; CROSS-OVER STUDIES; DESENSITIZATION, IMMUNOLOGIC; DRUG HYPERSENSITIVITY; FEMALE; HUMANS; MALE; MIDDLE AGED; NASAL POLYPS; PILOT PROJECTS; PROSPECTIVE STUDIES; RESPIRATORY TRACT DISEASES; RHINITIS; SALICYLATES; SINGLE-BLIND METHOD; SINUSITIS;

EID: 84920130000     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599814563497     Document Type: Erratum

References (43)

1. Widal FAP, Lermoyez J. Anaphylaxis and idiosyncraysies. Presse Med. 1922 ; 30: 189
2. Samter M, Beers RF. Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med. 1968 ; 68: 975-983
3. Samter M, Beers RF. Concerning the nature of intolerance to aspirin. J Allergy. 1967 ; 40: 281-293
4. Laidlaw TM, Boyce JA. Pathogenesis of aspirin-exacerbated respiratory disease and reactions. Immunol Allergy Clin North Am. 2013 ; 33: 195-210
5. Rizk H. Role of aspirin desensitization in the management of chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg. 2011 ; 19: 210-217
6. Szczeklik A, Nizankowska E, Duplaga M. Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-Induced Asthma. Eur Respir J. 2000 ; 16: 432-436
7. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol. 2003 ; 111: 913-921
8. Berges-Gimeno M, Simon RA, Stevenson DD. The natural history and clinical characteristics of aspirin exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2002 ; 89: 474-478
9. Kowalski ML. Aspirin-sensitive rhinosinusitis and asthma. Clin Allergy Immunol. 2007 ; 19: 147-175
10. Vento SI, Ertama LO, Hytonen ML, Wolff CH, Malmberg CH. Nasal polyposis: clinical course during 20 years. Ann Allergy Asthma Immunol. 2000 ; 85: 209-214
11. Jantii-Alanco S, Holopainen E, Malmberg H. Recurrence of nasal polyps after surgical treatment. Rhinology. 1989 ; 8: 59-64
12. Rotenberg BW, Zhang I, Arra I, Payton KB. Postoperative care for Samter's triad patients undergoing endoscopic sinus surgery: a double-blinded, randomized controlled trial. Laryngoscope. 2011 ; 121: 2702-2705
13. Xu JJ, Sowerby L, Rotenberg BW. Aspirin desensitization for aspirin-exacerbated respiratory disease (Samter's Triad): a systematic review of the literature. Int Forum Allergy Rhinol. 2013 ; 3: 915-920
14. Mitchell J, Skypala I. Aspirin and salicylate in respiratory disease. Rhinology. 2013 ; 51: 195-205
15. Cook PR. The role of aspirin sensitivity and nasal polyposis. Curr Opin Otolaryngol Head Neck Surg. 2002 ; 10: 213-216
16. Klimek L, Pfaar O. Aspirin intolerance: does desensitization alter the course of the disease?. Immunol Allergy Clin North America. 2009 ; 29: 669-675
17. Hare LG, Woodside JV, Young IS. Dietary salicylates. J Clin Pathol. 2003 ; 56: 649-650
18. Dahlén B, Boréus LO, Anderson P, Andersson R, Zetterström O. Plasma acetylsalicylic acid and salicylic acid levels during aspirin provocation in aspirin-sensitive subjects. Allergy. 1994 ; 49: 43-49
19. Koschel D, Weber CN, Hoffken G. Tolerability to etoricoxib in patients with aspirin-exacerbated respiratory disease. J Investig Allergol Clin Immunol. 2013 ; 23: 275-280
20. Umemoto J, Tsuriksawa N, Nogi S, et al. Selective cyclooxygenase-2 inhibitor cross-reactivity in aspirin exacerbated respiratory disease. Allergy Asthma Proc. 2011 ; 32: 259-261
21. Hopkins C, Gillett S, Slack R, Lund VJ, Browne JP. Psychometric validity of the 22-item Sinonasal Outcome Test. Clin Otolaryngol. 2009 ; 34: 447-454
22. Amann R, Peskar BA. Anti-inflammatory effects of aspirin and sodium salicylate. Eur J Pharmacol. 2002 ; 447: 1-9
23. Venema DP, Hollman PCH, Janssen KP, Katan MB. Determination of acetylsalicylic acid and salicylic acid in foods, using HPLC with fluorescence detection. J Agric Food Chem. 1996 ; 44: 1762-1767
24. Robertson GL, Kermode WJ. Salicylic acid in fresh and canned fruit and vegetables. J Sci Food Agric. 1981 ; 32: 833-836
25. Janssen KTLPM, Hollman PCH, Venema DP, van Staveren WA, Katan MB. Salicylates in Foods. Nut Reviews. 1996 ; 54: 357-359
26. Herrman K. Occurrence and content of hydroxycinnamic and hydroxybenzoic compounds in foods. Crit Rev Food Sci Nutr. 1989 ; 28: 4315-4347
27. Swain AR, Dutton SP, Truswell AS. Salicylates in foods. J Am Diet Assoc. 1985 ; 85: 950-960
28. Scotter MJ, Roberts DPT, Wilson LA, et al. Free salicylic acid and acetyl salicylic acid content of foods using gas chromatography-mass spectrometry. Food Chem. 2007 ; 105: 273-279
29. Paterson JR, Srivastava R, Baxter GJ, et al. Salicylic acid content of spices and its implications. J Agric Food Chem. 2006 ; 54: 2891-2896
30. Wood A, Baxter G, Thies F, Kyle J, Duthie G. A systematic review of salicylates in food: Estimated daily intake of a Scottish population. Mol Nutr Food Res. 2011 ;: S7 - S14
31. Baxter GJ, Graham AB, Lawrence JR, Wiles D, Paterson JR. Salicylic acid in soups pre- pared from organically and non-organically grown vegetables. Eur J Nutr. 2001 ; 40: 289-292
32. Heiska S, Rousi M, Turtola S, Meier B, Tirkkonen V, Julkunen-Titto R. The effect of genotype and cultivation method on the total salicylate yield of dark leaved willows. Plant Medica. 2005 ; 71: 1134-1139
33. Lee RU, Stevenson DD. Aspirin-exacerbated respiratory disease: evaluation and management. Allergy Asthma Immunol Res. 2011 ; 3: 3-10
34. Jenkins C, Costello J, Hodge L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ. 2004 ; 328: 434-441
35. DeMarcantonio JK, Han N. Nasal polyps: pathogenesis and treatment implications. Otolaryngol Clin of North Am. 2011 ; 44: 684-695
36. Patrignani P, Dovizio M. Inside platelet-leukocyte cross-talk. Blood. 2012 ; 119: 3649-3650
37. Morales DR, Lipworth BJ, Guthrie B, et al. Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2 inhibitors: Meta-analysis of controlled clinical trials. J Allergy Clin Immunol. 2014 ; 134: 40-45
38. Moore-Robinson M, Warin RP. Effect of salicylates in urticaria. BMJ. 1967 ; 4: 262-264
39. Doeglas HMG. Reactions to aspirin and food additives in patients with chronic urticaria including the physical urticarias. Br J Dermatol. 1975 ; 93: 135-144
40. Ros AM, Juhlin L, Michaelsson G. A follow-up study of patients with recurrent urticaria and hypersensitivity to aspirin, benzoates and azo dyes. Br J Dermatol. 1976 ; 95: 19-24
41. Juhlin L. Recurrent urticaria: clinical investigation of 330 patients. Br J Dermatol. 1981 ; 104: 369-381
42. Sweet JM, Stevenson DD, Simon RA, Mathison DA. Long-term effects of aspirin desensitization-Treatment for aspirin-sensitive rhinosinusitis-asthma. J Allergy Clin Immunol. 1990 ; 85: 59-65
43. Sibblad B, Roberts C. Understanding controlled trials crossover trials. BMJ. 1998 1719 ; 316 :